Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of dutasteride on prostate cancer volume and MRI characteristics in low-risk prostate cancer
2009-012405-18Phase 2Completed
- Sponsor
- University College London
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in prostate cancer (PCa) comparing Dutasteride arm with Placebo arm (2 arms). Primary endpoint: Percentage change in prostate cancer volume by T2-weighted MRI. Started Mar 2010; status: completed.
02
Drugs
dutasteride
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2009-012405-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012405-18.